Company
Balyasny Asset Management
Investments
| Company | Round | Date | Lead |
|---|---|---|---|
| Expedition Therapeutics | Series B | 2026-08-05 | |
| Lycia Therapeutics | Series D | 2026-06-29 | Lead |
| Oak Hill Bio | Series A | 2026-06-03 | Lead |
| Solve Therapeutics | Funding | 2025-11-17 | |
| Forterra | Series C | 2025-11-13 |